Clinical Trials Browser

Completed × Interventional × ralimetinib × Clear all

NCT01393990 2020-03-24

A Study of LY2228820 in Participants With Advanced Cancer

Phase 1 Completed

89 enrolled 30 charts

Advanced Cancer

NCT02364206 2019-08-14

GLYRad

Phase 1/2 Completed

Glioblastoma

NCT02860780 2018-12-14

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Phase 1 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Colorectal Neoplasms